Panion BF (Taiwan) Insiders
| 1760 Stock | TWD 82.20 0.50 0.61% |
Panion BF employs about 16 people. The company is managed by 15 executives with a total tenure of roughly 203 years, averaging almost 13.0 years of service per executive, having 1.07 employees per reported executive. Recap of Panion BF's management performance can provide insight into the venture performance.
| WengFoung Huang Insider Director |
| Fengren Wang Insider Deputy General Manager |
Panion |
Panion BF Management Team Effectiveness
The company has return on total asset (ROA) of 0.0805 % which means that it generated a profit of $0.0805 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1355 %, meaning that it generated $0.1355 on every $100 dollars invested by stockholders. Panion BF's management efficiency ratios could be used to measure how well Panion BF manages its routine affairs as well as how well it operates its assets and liabilities.Panion BF Workforce Comparison
Panion BF Biotech is number one stock in number of employees category among its peers. The total workforce of Biotechnology industry is presently estimated at about 124. Panion BF retains roughly 16.0 in number of employees claiming about 13% of stocks in Biotechnology industry.
The company has Profit Margin (PM) of 0.11 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.17 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.17. Panion BF Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Panion BF Biotech Price Series Summation is a cross summation of Panion BF price series and its benchmark/peer.
Panion BF Notable Stakeholders
A Panion BF stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Panion BF often face trade-offs trying to please all of them. Panion BF's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Panion BF's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| WengFoung Huang | Director | Profile | |
| Fengren Wang | Deputy General Manager | Profile | |
| Riyan Zhang | Independent Director | Profile | |
| Jizhou Liao | Independent Director | Profile | |
| Chongqi Cai | Director | Profile | |
| Zhiming Lin | Director | Profile | |
| ChungChi Tsai | VP | Profile | |
| Defu Xie | Director | Profile | |
| Li Chang | Chairman of the Board | Profile | |
| Chung Chiang | General Manager, Director | Profile | |
| Junping Lu | Deputy General Manager | Profile | |
| Jinxuan Chen | Independent Director | Profile | |
| Qingsui Yi | Director | Profile | |
| Junda Zheng | Director | Profile | |
| Wenting Ke | Deputy General Manager | Profile |
About Panion BF Management Performance
The success or failure of an entity such as Panion BF Biotech often depends on how effective the management is. Panion BF management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Panion management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Panion management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Panion Bf Biotech Inc., a biotechnology pharmaceutical company, manufactures and sells various pharmaceutical products in Taiwan. Panion Bf Biotech Inc. was founded in 1976 and is headquartered in Taipei City, Taiwan. PANION BF operates under Biotechnology classification in Taiwan and is traded on Taiwan Stock Exchange.
Please note, the imprecision that can be found in Panion BF's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Panion BF Biotech. Check Panion BF's Beneish M Score to see the likelihood of Panion BF's management manipulating its earnings.
Panion BF Workforce Analysis
Traditionally, organizations such as Panion BF use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Panion BF within its industry.Panion BF Manpower Efficiency
Return on Panion BF Manpower
| Revenue Per Employee | 118.8M | |
| Revenue Per Executive | 126.7M | |
| Net Income Per Employee | 6.5M | |
| Net Income Per Executive | 7M |
Additional Tools for Panion Stock Analysis
When running Panion BF's price analysis, check to measure Panion BF's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Panion BF is operating at the current time. Most of Panion BF's value examination focuses on studying past and present price action to predict the probability of Panion BF's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Panion BF's price. Additionally, you may evaluate how the addition of Panion BF to your portfolios can decrease your overall portfolio volatility.